These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Analysis of the beta-amyloid protein precursor of Alzheimer's disease: mRNAs and protein products. Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T Adv Neurol; 1990; 51():181-4. PubMed ID: 2104687 [No Abstract] [Full Text] [Related]
23. Alzheimer's disease and Abeta toxicity: from top to bottom. Small DH; Mok SS; Bornstein JC Nat Rev Neurosci; 2001 Aug; 2(8):595-8. PubMed ID: 11484003 [No Abstract] [Full Text] [Related]
24. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology? Muyllaert D; Kremer A; Jaworski T; Borghgraef P; Devijver H; Croes S; Dewachter I; Van Leuven F Genes Brain Behav; 2008 Feb; 7 Suppl 1():57-66. PubMed ID: 18184370 [TBL] [Abstract][Full Text] [Related]
25. beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Butterfield DA Chem Res Toxicol; 1997 May; 10(5):495-506. PubMed ID: 9168246 [No Abstract] [Full Text] [Related]
26. Amyloid, aluminium and the aetiology of Alzheimer's disease. Walton JR Med J Aust; 1996 Mar; 164(6):382-3. PubMed ID: 8606673 [No Abstract] [Full Text] [Related]
27. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Blass JP; Gibson GE Rev Neurol (Paris); 1991; 147(6-7):513-25. PubMed ID: 1962057 [TBL] [Abstract][Full Text] [Related]
28. Protein abnormalities in neurofibrillary tangles: their relation to the extracellular amyloid deposits of the A4 protein in Alzheimer's disease. Masters CL; Beyreuther K Adv Neurol; 1990; 51():151-61. PubMed ID: 1967195 [No Abstract] [Full Text] [Related]
29. Sporadic dementia of Alzheimer type: role of amyloid in etiology is challenged. Hoyer S J Neural Transm Park Dis Dement Sect; 1993; 6(3):159-65. PubMed ID: 8123189 [TBL] [Abstract][Full Text] [Related]
31. The blood-brain barrier in Alzheimer's disease and normal aging. Masters CL; Beyreuther K Neurobiol Aging; 1988; 9(1):43-4. PubMed ID: 3380251 [No Abstract] [Full Text] [Related]
32. The 2nd International Symposium on Alzheimer's disease and related disorders in the Middle East, May 1-3, 2003, Istanbul, Turkey. Geula C; Emre M; Friedland RP Amyloid; 2004 Dec; 11(4):276-80. PubMed ID: 15678765 [No Abstract] [Full Text] [Related]
33. Alzheimer's unlocked. Park A Time; 2010 Oct; 176(17):53-9. PubMed ID: 21049676 [No Abstract] [Full Text] [Related]
34. Alzheimer's disease: clinical trials and the amyloid hypothesis. Cummings J Ann Acad Med Singap; 2011 Jul; 40(7):304-6. PubMed ID: 21870020 [No Abstract] [Full Text] [Related]
35. Potential biological targets for anti-Alzheimer drugs. Allain H; Belliard S; de Certaines J; Bentué-Ferrer D; Bureau M; Lacroix P Dementia; 1993; 4(6):347-52. PubMed ID: 7907916 [TBL] [Abstract][Full Text] [Related]
36. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Jarrett JT; Lansbury PT Cell; 1993 Jun; 73(6):1055-8. PubMed ID: 8513491 [No Abstract] [Full Text] [Related]
37. Alzheimer's disease: a compendium of current theories. Proceedings of a conference. April 30-May 2, 1999. Orlando, Florida, USA. Ann N Y Acad Sci; 2000; 924():1-195. PubMed ID: 11193784 [No Abstract] [Full Text] [Related]
38. Alzheimer's disease: understanding homeostasis deregulation to foster development of effective therapies. Nisticò R; Peineau S Pharmacol Res; 2019 Jan; 139():467-468. PubMed ID: 30553822 [No Abstract] [Full Text] [Related]
39. Alzheimer's disease in males: endocrine issues and prospects. Lerner AJ J Clin Endocrinol Metab; 1999 Oct; 84(10):3416-9. PubMed ID: 10522973 [No Abstract] [Full Text] [Related]
40. Is angiogenesis a plausible hypothesis in Alzheimer's disease? Birkenhäger WH; Staessen JA J Hypertens; 2003 Jul; 21(7):1426-7. PubMed ID: 12817194 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]